Dose-intensive approaches to ovarian cancer.

N. Lambrou; E. L. Trimble

doi:10.1007/s11912-999-0010-x

Dose-intensive approaches to ovarian cancer.

N. Lambrou, E. L. Trimble

School of Medicine

Research output: Contribution to journal › Review article › peer-review

Abstract

Increasing the total dose or the dose intensity of platinum does not improve survival in women with ovarian cancer. High-dose chemotherapy with hematologic support has not been shown to be more effective than standard-dose chemotherapy. Regional dose intensity, through intraperitoneal chemotherapy, may have a role in the treatment of advanced ovarian cancer. Further studies are needed to identify the optimal combination of agents, in addition to a platinum and a taxane, to be used in primary therapy for ovarian cancer.

Original language	English (US)
Pages (from-to)	54-58
Number of pages	5
Journal	Current oncology reports
Volume	1
Issue number	1
DOIs	https://doi.org/10.1007/s11912-999-0010-x
State	Published - Sep 1999

ASJC Scopus subject areas

Oncology

Access to Document

10.1007/s11912-999-0010-x

Fingerprint Dive into the research topics of 'Dose-intensive approaches to ovarian cancer.'. Together they form a unique fingerprint.

Cite this

@article{06c8c06f96d44f3f8862465ced29af51,

title = "Dose-intensive approaches to ovarian cancer.",

abstract = "Increasing the total dose or the dose intensity of platinum does not improve survival in women with ovarian cancer. High-dose chemotherapy with hematologic support has not been shown to be more effective than standard-dose chemotherapy. Regional dose intensity, through intraperitoneal chemotherapy, may have a role in the treatment of advanced ovarian cancer. Further studies are needed to identify the optimal combination of agents, in addition to a platinum and a taxane, to be used in primary therapy for ovarian cancer.",

author = "N. Lambrou and Trimble, {E. L.}",

year = "1999",

month = sep,

doi = "10.1007/s11912-999-0010-x",

language = "English (US)",

volume = "1",

pages = "54--58",

journal = "Current Oncology Reports",

issn = "1523-3790",

publisher = "Current Science, Inc.",

number = "1",

}

TY - JOUR

T1 - Dose-intensive approaches to ovarian cancer.

AU - Lambrou, N.

AU - Trimble, E. L.

PY - 1999/9

Y1 - 1999/9

N2 - Increasing the total dose or the dose intensity of platinum does not improve survival in women with ovarian cancer. High-dose chemotherapy with hematologic support has not been shown to be more effective than standard-dose chemotherapy. Regional dose intensity, through intraperitoneal chemotherapy, may have a role in the treatment of advanced ovarian cancer. Further studies are needed to identify the optimal combination of agents, in addition to a platinum and a taxane, to be used in primary therapy for ovarian cancer.

AB - Increasing the total dose or the dose intensity of platinum does not improve survival in women with ovarian cancer. High-dose chemotherapy with hematologic support has not been shown to be more effective than standard-dose chemotherapy. Regional dose intensity, through intraperitoneal chemotherapy, may have a role in the treatment of advanced ovarian cancer. Further studies are needed to identify the optimal combination of agents, in addition to a platinum and a taxane, to be used in primary therapy for ovarian cancer.

UR - http://www.scopus.com/inward/record.url?scp=0033187931&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033187931&partnerID=8YFLogxK

U2 - 10.1007/s11912-999-0010-x

DO - 10.1007/s11912-999-0010-x

M3 - Review article

C2 - 11122798

AN - SCOPUS:0033187931

VL - 1

SP - 54

EP - 58

JO - Current Oncology Reports

JF - Current Oncology Reports

SN - 1523-3790

IS - 1

ER -

Dose-intensive approaches to ovarian cancer.

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this